Evidence map›Paper›PMID 27051666›Full record

ReviewBioMed research international2016

Eclectic Ocular Comorbidities and Systemic Diseases with Eye Involvement: A Review.

María D Pinazo-Durán, Vicente Zanón-Moreno, José J García-Medina, J Fernando Arévalo, Roberto Gallego-Pinazo, Carlo Nucci

Abstract readReview
In one paragraph

Review in BioMed research international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Demography, clinical profile and risk of retinal vein occlusion among patients with age-related macular degeneration - a tertiary hospital based study.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Ocular complications with the use of radium-223: a case series.Radiation oncology (London, England) · 2022
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

María D Pinazo-DuránOphthalmic Research Unit "Santiago Grisolía", Fundación Investigación Biomédica y Sanitaria (FISABIO), Avenida Gaspar Aguilar 90, 46017 Valencia, Spain; Ophthalmology Research Unit, Department of Surgery, Faculty of Medicine and Odontology, University of Valencia, Avenida Blasco Ibáñez 15, 46010 Valencia, Spain; Spanish Net of Ophthalmic Pathology (OFTARED), Instituto de Salud Carlos III, C/Sinesio Delgado 4, 28029 Madrid, Spain.ORCID 0000-0002-0823-8836
Vicente Zanón-MorenoOphthalmic Research Unit "Santiago Grisolía", Fundación Investigación Biomédica y Sanitaria (FISABIO), Avenida Gaspar Aguilar 90, 46017 Valencia, Spain; Ophthalmology Research Unit, Department of Surgery, Faculty of Medicine and Odontology, University of Valencia, Avenida Blasco Ibáñez 15, 46010 Valencia, Spain.
José J García-MedinaOphthalmic Research Unit "Santiago Grisolía", Fundación Investigación Biomédica y Sanitaria (FISABIO), Avenida Gaspar Aguilar 90, 46017 Valencia, Spain; Spanish Net of Ophthalmic Pathology (OFTARED), Instituto de Salud Carlos III, C/Sinesio Delgado 4, 28029 Madrid, Spain; Ophthalmology Department, University Hospital Reina Sofia, Avenida Intendente Jorge Palacios 1, 30003 Murcia, Spain.
J Fernando ArévaloRetina Division, The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Nelson Building, 600 N. Wolf Street, Baltimore, MD 21287, USA.
Roberto Gallego-PinazoOphthalmic Research Unit "Santiago Grisolía", Fundación Investigación Biomédica y Sanitaria (FISABIO), Avenida Gaspar Aguilar 90, 46017 Valencia, Spain; Spanish Net of Ophthalmic Pathology (OFTARED), Instituto de Salud Carlos III, C/Sinesio Delgado 4, 28029 Madrid, Spain; Department of Ophthalmology, University and Polytechnic Hospital La Fe, Avenida Fernando Abril Martorell 106, 46026 Valencia, Spain.
Carlo NucciOphthalmic Unit, Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, 81 Oxford Street, 00133 Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coexistence of several ocular diseases is more frequent than suspected. In spite of the refractive errors, one or more of the following can be detected simultaneously: glaucoma, cataracts, uveitis, age-related macular degeneration, and dry eyes. In addition, as people age, ocular comorbidities are much more usually seen. Specific diseases are openly acknowledged to affect the eyes and vision, such as diabetes mellitus, hypertension blood pressure, arthritis, hyperthyroidism, neurodegenerative disorders, hematologic malignancies, and/or systemic infections. Recent advances in early diagnosis and therapy of the ophthalmic pathologies have reinforced patient options to prevent visual impairment and blindness. Because of this, it is essential not to overlook sight-threatening conditions such as the ocular comorbidities and/or the eye involvement in the context of systemic disorders. Moreover, the important role of the multidisciplinary cooperation to improve and sustain management of patients affected with eclectic ocular comorbidities and/or systemic disorders with eye repercussion is specifically addressed. This review intends to shed light on these topics to help in making opportune diagnosis and appropriately managing the affected patients.

Indexed as

Eye DiseasesComorbidityHumans

Identifiers

PMID27051666
PMCPMC4808667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.